Do Not Stop Taking Folic Acid—But Address Your B12 Status Immediately
You should continue folic acid supplementation while simultaneously ensuring adequate vitamin B12 replacement to prevent irreversible neurological damage from pernicious anemia. The presence of intrinsic factor antibodies indicates you likely have or will develop pernicious anemia, making B12 treatment the priority—not stopping folic acid.
The Critical Issue: B12 Deficiency, Not Folic Acid Toxicity
The concern about high-dose folic acid in pernicious anemia is masking—not causing—the underlying B12 deficiency. Here's what actually happens:
- Folic acid can correct the anemia of pernicious anemia, making blood counts look normal 1
- However, neurological damage from B12 deficiency continues to progress silently in the background 1
- The real danger is delayed diagnosis, not the folic acid itself 2
The FDA label explicitly warns that folic acid doses above 0.4 mg daily may "obscure pernicious anemia in that hematologic remission can occur while neurologic manifestations remain progressive" 1.
Your Immediate Action Plan
1. Start B12 Replacement Now
- With positive intrinsic factor antibodies, you have confirmed or impending pernicious anemia 3, 4
- Begin parenteral (intramuscular) vitamin B12 therapy immediately—oral B12 won't work adequately in pernicious anemia due to malabsorption
- Typical regimen: 1000 mcg IM daily or every other day until neurological symptoms stabilize, then monthly maintenance
2. Continue Your Folic Acid
- If you're taking high-dose folic acid for neural tube defect prevention (pregnancy planning), continue as prescribed
- The guideline recommendation is clear: folic acid supplementation is "unlikely to mask vitamin B12 deficiency" when taken in a multivitamin that includes 2.6 mcg/day of B12 5
- The key is treating both deficiencies simultaneously, not stopping one to diagnose the other
3. Verify Your B12 Status Carefully
A critical pitfall: Your serum B12 level may be falsely normal or even elevated due to assay interference from the same intrinsic factor antibodies you have 4, 6. This is a well-documented diagnostic trap where:
- Anti-intrinsic factor antibodies interfere with competitive binding chemiluminescence assays
- B12 levels can read >2000 pmol/L despite severe deficiency 4
- Patients present with megaloblastic changes but "normal" B12 results 6
Request these tests instead:
- Methylmalonic acid (MMA)—elevated in true B12 deficiency
- Homocysteine—elevated in B12 deficiency
- Consider alternative B12 assay methods if available (electrochemiluminescence) 6
Why This Approach Prioritizes Your Outcomes
Morbidity & Mortality Considerations:
- Untreated B12 deficiency causes irreversible neurological damage: subacute combined degeneration of the spinal cord, peripheral neuropathy, cognitive impairment 3
- Stopping folic acid provides no benefit and may increase your risk of neural tube defects if you become pregnant
- The historical concern about "masking" was based on delayed diagnosis in an era before modern testing—not actual harm from folic acid itself 2
Quality of Life Impact:
Recent evidence shows that patients with low B12 and elevated folate have worse cognitive function and higher homocysteine/MMA than those with low B12 and normal folate 7. However, this reflects untreated B12 deficiency, not folic acid toxicity. The solution is B12 replacement, not folic acid cessation.
Common Pitfalls to Avoid
Don't wait for anemia to develop before treating B12 deficiency—neuropsychiatric symptoms often precede hematologic changes 3
Don't rely solely on serum B12 levels with positive intrinsic factor antibodies—they're unreliable 4, 6
Don't stop folic acid to "unmask" B12 deficiency—this outdated approach delays necessary treatment and provides no diagnostic advantage with modern testing
Don't take oral B12 supplements thinking they'll suffice—pernicious anemia requires parenteral replacement due to intrinsic factor deficiency
The Bottom Line
Your intrinsic factor antibodies indicate you need lifelong B12 replacement therapy, not folic acid discontinuation. The 2015 Canadian guideline explicitly states that "folic acid supplementation is unlikely to mask vitamin B12 deficiency" and recommends taking folic acid in a multivitamin that includes B12 5. The USPSTF found "no evidence to support" the harm of masking, noting that B12 depletion affects less than 1% of reproductive-age women 8.
Continue your folic acid as prescribed and immediately initiate B12 therapy with your physician. This dual approach prevents both neural tube defects (if pregnancy occurs) and irreversible neurological damage from pernicious anemia—optimizing all three priority outcomes: morbidity, mortality, and quality of life.